1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
86.85%
Positive EBIT growth while OGI.TO is negative. John Neff might see a substantial edge in operational management.
86.85%
Positive operating income growth while OGI.TO is negative. John Neff might view this as a competitive edge in operations.
87.46%
Positive net income growth while OGI.TO is negative. John Neff might see a big relative performance advantage.
87.70%
EPS growth above 1.5x OGI.TO's 28.75%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
87.70%
Diluted EPS growth above 1.5x OGI.TO's 28.75%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1323.70%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-1323.70%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1020.71%
Negative 10Y OCF/share CAGR while OGI.TO stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-1020.71%
Negative 5Y OCF/share CAGR while OGI.TO is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-1020.71%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
38.34%
10Y net income/share CAGR of 38.34% while OGI.TO is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
38.34%
Net income/share CAGR of 38.34% while OGI.TO is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
38.34%
Positive short-term CAGR while OGI.TO is negative. John Neff would see a clear advantage in near-term profit trajectory.
-57.28%
Negative equity/share CAGR over 10 years while OGI.TO stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-57.28%
Negative 5Y equity/share growth while OGI.TO is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-57.28%
Negative 3Y equity/share growth while OGI.TO is at 196.62%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-69.26%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
-32.28%
Negative asset growth while OGI.TO invests at 18.18%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-5.59%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-104.07%
We cut SG&A while OGI.TO invests at 236.45%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.